Pulmonary Hypertension Observational Study

NCT05958901 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 10000

Last updated 2023-07-25

No results posted yet for this study

Summary

The purpose of this study is to establish the large PH cohort and biological database in China, aiming for precision medicine to optimize diagnosis and treatment choices.

Conditions

  • Pulmonary Hypertension

Interventions

OTHER

pulmonary hypertension

The final outcome observed was a diagnosis of pulmonary hypertension.

Sponsors & Collaborators

  • The First Affiliated Hospital of Guangzhou Medical University

    lead OTHER

Eligibility

Min Age
20 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-07-12
Primary Completion
2025-12-30
Completion
2027-12-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05958901 on ClinicalTrials.gov